$10.3MSeries B, 13 January 2026
Series B1 funds enrollment in the RESTORE pivotal trial of DBS combined with rehabilitation.
- Amount
- $10.3M
- Stage
- Series B
- Announced
- 13 January 2026
- Lead
- Genesys Capital
- Other investors
- Cleveland Clinic, JobsOhio Ventures
- Use of funds
- Series B1 funds enrollment in the RESTORE pivotal trial of DBS combined with rehabilitation.
- Checked
- Announced by the company
- Sources
- Enspire DBS Therapy Secured $10.3 Million Series B1 To Advance DBS-Enabled Stroke Rehabilitation Trial biospace.com
Enspire DBS Therapy Secured $10.3 Million Series B1 To Advance DBS-Enabled Stroke Rehabilitation Trial pulse2.com